Resources

Baxter is committed to providing you with useful tools delivering clinical information about human albumin therapies. We hope the resources below will be helpful and answer questions you might have about albumin therapy or our offerings in the field.

FLEXBUMIN 25% [Albumin (Human)], 25% Solution White Paper

Learn about FLEXBUMIN 25% in this comprehensive study.

Download White Paper

Albumin Slide Kit

Download our slide kit for either personal reference or professional presentation.

Download Slides

FLEXBUMIN 25% [Albumin (Human)], 25% Solution Information Sheet

Learn about the benefits of FLEXBUMIN 25%, the first and only formulation of human albumin available in a flexible container.

Download Information Sheet

FLEXBUMIN 25% [Albumin (Human)]

FLEXBUMIN 25%, Albumin (Human), USP, 25% Solution is a sterile, nonpyrogenic preparation of albumin in a single dosage form for intravenous administration. FLEXBUMIN 25% is indicated for hypovolemia, hypoalbuminemia due to general causes, burns, adult respiratory distress syndrome (ARDS), and nephrosis, and for use during or prior to cardiopulmonary bypass surgery, and hemolytic disease of the newborn (HDN).

Please see Important Risk Information for FLEXBUMIN 25% and Full Prescribing Information.

BUMINATE 5% [Albumin (Human)], USP, 5% Solution

BUMINATE 5%, Albumin (Human), USP, 5% Solution is indicated for Hypovolemia, Hypoalbuminemia due to general causes and burns, and use during or prior to cardiopulmonary bypass surgery.

Please see Important Risk Information for BUMINATE 5% and Full Prescribing Information.

BUMINATE 25% [Albumin (Human)], USP, 25% Solution

Buminate 25%, Albumin (Human), USP, 25% Solution is indicated for Hypovolemia, Hypoalbuminemia due to general causes, burns, adult respiratory distress syndrome (ARDS), and nephrosis, for use during or prior to cardiopulmonary bypass surgery, and Hemolytic disease of the newborn (HDN).

Please see Important Risk Information for BUMINATE 25% and Full Prescribing Information.